168 related articles for article (PubMed ID: 18214996)
1. Retargeting polymer-coated adenovirus to the FGF receptor allows productive infection and mediates efficacy in a peritoneal model of human ovarian cancer.
Green NK; Morrison J; Hale S; Briggs SS; Stevenson M; Subr V; Ulbrich K; Chandler L; Mautner V; Seymour LW; Fisher KD
J Gene Med; 2008 Mar; 10(3):280-9. PubMed ID: 18214996
[TBL] [Abstract][Full Text] [Related]
2. Virotherapy of ovarian cancer with polymer-cloaked adenovirus retargeted to the epidermal growth factor receptor.
Morrison J; Briggs SS; Green N; Fisher K; Subr V; Ulbrich K; Kehoe S; Seymour LW
Mol Ther; 2008 Feb; 16(2):244-51. PubMed ID: 18071336
[TBL] [Abstract][Full Text] [Related]
3. Cetuximab retargeting of adenovirus via the epidermal growth factor receptor for treatment of intraperitoneal ovarian cancer.
Morrison J; Briggs SS; Green NK; Thoma C; Fisher KD; Kehoe S; Seymour LW
Hum Gene Ther; 2009 Mar; 20(3):239-51. PubMed ID: 19257852
[TBL] [Abstract][Full Text] [Related]
4. Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies.
Fisher KD; Stallwood Y; Green NK; Ulbrich K; Mautner V; Seymour LW
Gene Ther; 2001 Mar; 8(5):341-8. PubMed ID: 11313809
[TBL] [Abstract][Full Text] [Related]
5. Uptake of adenoviral vectors via fibroblast growth factor receptors involves intracellular pathways that differ from the targeting ligand.
Hoganson DK; Sosnowski BA; Pierce GF; Doukas J
Mol Ther; 2001 Jan; 3(1):105-12. PubMed ID: 11162317
[TBL] [Abstract][Full Text] [Related]
6. E-selectin is a viable route of infection for polymer-coated adenovirus retargeting in TNF-α-activated human umbilical vein endothelial cells.
Bachtarzi H; Stevenson M; Subr V; Seymour LW; Fisher KD
J Drug Target; 2011 Sep; 19(8):690-700. PubMed ID: 21309681
[TBL] [Abstract][Full Text] [Related]
7. Systemic image-guided liver cancer radiovirotherapy using dendrimer-coated adenovirus encoding the sodium iodide symporter as theranostic gene.
Grünwald GK; Vetter A; Klutz K; Willhauck MJ; Schwenk N; Senekowitsch-Schmidtke R; Schwaiger M; Zach C; Wagner E; Göke B; Holm PS; Ogris M; Spitzweg C
J Nucl Med; 2013 Aug; 54(8):1450-7. PubMed ID: 23843567
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor-2-retargeted adenoviral vector for selective transduction of primary glioblastoma multiforme endothelial cells.
Gupta V; Wang W; Sosnowski BA; Hofman FM; Chen TC
Neurosurg Focus; 2006 Apr; 20(4):E26. PubMed ID: 16709032
[TBL] [Abstract][Full Text] [Related]
9. Incorporation of a laminin-derived peptide (SIKVAV) on polymer-modified adenovirus permits tumor-specific targeting via alpha6-integrins.
Stevenson M; Hale AB; Hale SJ; Green NK; Black G; Fisher KD; Ulbrich K; Fabra A; Seymour LW
Cancer Gene Ther; 2007 Apr; 14(4):335-45. PubMed ID: 17235355
[TBL] [Abstract][Full Text] [Related]
10. Targeting EGFR with metabolically biotinylated fiber-mosaic adenovirus.
Pereboeva L; Komarova S; Roth J; Ponnazhagan S; Curiel DT
Gene Ther; 2007 Apr; 14(8):627-37. PubMed ID: 17251987
[TBL] [Abstract][Full Text] [Related]
11. Retargeting of adenoviral vector using basic fibroblast growth factor ligand for malignant glioma gene therapy.
Wang W; Zhu NL; Chua J; Swenson S; Costa FK; Schmitmeier S; Sosnowski BA; Shichinohe T; Kasahara N; Chen TC
J Neurosurg; 2005 Dec; 103(6):1058-66. PubMed ID: 16381193
[TBL] [Abstract][Full Text] [Related]
12. Experimental treatment of ovarian cancers by adenovirus vectors combining receptor targeting and selective expression of tumor necrosis factor.
Murugesan SR; Akiyama M; Einfeld DA; Wickham TJ; King CR
Int J Oncol; 2007 Oct; 31(4):813-22. PubMed ID: 17786312
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor 2-retargeted adenoviral vectors exhibit a modified biolocalization pattern and display reduced toxicity relative to native adenoviral vectors.
Printz MA; Gonzalez AM; Cunningham M; Gu DL; Ong M; Pierce GF; Aukerman SL
Hum Gene Ther; 2000 Jan; 11(1):191-204. PubMed ID: 10646650
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor 2 retargeted adenovirus has redirected cellular tropism: evidence for reduced toxicity and enhanced antitumor activity in mice.
Gu DL; Gonzalez AM; Printz MA; Doukas J; Ying W; D'Andrea M; Hoganson DK; Curiel DT; Douglas JT; Sosnowski BA; Baird A; Aukerman SL; Pierce GF
Cancer Res; 1999 Jun; 59(11):2608-14. PubMed ID: 10363982
[TBL] [Abstract][Full Text] [Related]
15. Preclinical evaluation of a class of infectivity-enhanced adenoviral vectors in ovarian cancer gene therapy.
Wu H; Han T; Lam JT; Leath CA; Dmitriev I; Kashentseva E; Barnes MN; Alvarez RD; Curiel DT
Gene Ther; 2004 May; 11(10):874-8. PubMed ID: 14999229
[TBL] [Abstract][Full Text] [Related]
16. Extended plasma circulation time and decreased toxicity of polymer-coated adenovirus.
Green NK; Herbert CW; Hale SJ; Hale AB; Mautner V; Harkins R; Hermiston T; Ulbrich K; Fisher KD; Seymour LW
Gene Ther; 2004 Aug; 11(16):1256-63. PubMed ID: 15215884
[TBL] [Abstract][Full Text] [Related]
17. Combined transductional untargeting/retargeting and transcriptional restriction enhances adenovirus gene targeting and therapy for hepatic colorectal cancer tumors.
Li HJ; Everts M; Yamamoto M; Curiel DT; Herschman HR
Cancer Res; 2009 Jan; 69(2):554-64. PubMed ID: 19147569
[TBL] [Abstract][Full Text] [Related]
18. Chick embryo lethal orphan virus can be polymer-coated and retargeted to infect mammalian cells.
Stevenson M; Boos E; Herbert C; Hale A; Green N; Lyons M; Chandler L; Ulbrich K; van Rooijen N; Mautner V; Fisher K; Seymour L
Gene Ther; 2006 Feb; 13(4):356-68. PubMed ID: 16355117
[TBL] [Abstract][Full Text] [Related]
19. Combined transcriptional and transductional targeting improves the specificity and efficacy of adenoviral gene delivery to ovarian carcinoma.
Barker SD; Dmitriev IP; Nettelbeck DM; Liu B; Rivera AA; Alvarez RD; Curiel DT; Hemminki A
Gene Ther; 2003 Jul; 10(14):1198-204. PubMed ID: 12833129
[TBL] [Abstract][Full Text] [Related]
20. The transduction of Coxsackie and Adenovirus Receptor-negative cells and protection against neutralizing antibodies by HPMA-co-oligolysine copolymer-coated adenovirus.
Wang CH; Chan LW; Johnson RN; Chu DS; Shi J; Schellinger JG; Lieber A; Pun SH
Biomaterials; 2011 Dec; 32(35):9536-45. PubMed ID: 21959008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
